+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antibodies to neural proteins in organophosphorus-induced delayed neuropathy (OPIDN) and its amelioration



Antibodies to neural proteins in organophosphorus-induced delayed neuropathy (OPIDN) and its amelioration



Neurotoxicology and Teratology 30(3): 161-166



The development of OPIDN and the efficacy of experimental intervention using the calcium-channel blocker verapamil were used as a model to test the serial time-measurements of serum autoantibodies against neuronal cytoskeletal proteins [e.g., neurofilament triplet (NF)] and glial proteins [myelin-basic protein (MBP) and glial fibrillary-acidic protein (GFAP)] as biomarkers of neurotoxicity and its amelioration. Ten White Leghorn hens (>7 months, 1.2-1.8 kg) were administered phenyl-saligenin phosphate (PSP; 2.5 mg/kg; im), a dose reported to induce a 70% decrease in neurotoxic esterase (NTE) activity. Five of the hens were administered verapamil (7 mg/kg; im) for 4 days starting one day before PSP administration. Serum was isolated from blood collected by serial brachial venepuncture before PSP (day 0) administration and on days 3, 7 and 21 after PSP administration, each hen acting as its own control. Serum antibodies (IgG) to NF-L, NF-M, NF-H, MBP, and GFAP were assayed using an ELISA. There were no detectable levels of antibodies on days 0 and 3. IgG against all neural proteins were detected on days 7 and 21, with titer levels being significantly (p< or =0.05) higher in sera of hens receiving PSP only. Anti-NF-L titers were highest compared to those against NF-M, NF-H or MBP at 21 days. Titers of anti-NF-L and anti-MBP significantly (p< or =0.01) correlated with clinical scores at days 7 and 21. Detection of anti-NF and anti-MBP antibodies confirms the neuroaxonal degeneration accompanied by myelin loss reported in this model of OPIDN and the amelioration of neuropathy using verapamil. The detection of anti-GFAP antibodies suggests CNS involvement in OPIDN, since astrocytes are only found therein. This study demonstrates that detection of neuroantibodies can be used as biomarkers of neuropathy development and to monitor the amelioration resulting from therapeutic intervention. Together with biomarkers of exposure neuroantibodies can be used to monitor neuropathogenesis due to environmental or occupational exposures.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 030112595

Download citation: RISBibTeXText

PMID: 18353611

DOI: 10.1016/j.ntt.2008.01.005


Related references

Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN). Toxicology and Applied Pharmacology 107(2): 311-324, 1991

Immunohistochemical study of phosphorylated neurofilaments during the evolution of organophosphorus ester-induced delayed neuropathy (OPIDN). Neurotoxicology (Little Rock) 20(6): 971-976, 1999

Immunohistochemical study of phosphorylated neurofilaments during the evolution of organophosphorus ester-induced delayed neuropathy (OPIDN). Neurotoxicology 20(6): 971-975, 1999

Calpain activity in organophosphorus-induced delayed neuropathy (OPIDN): effects of a phenylalkylamine calcium channel blocker. Annals of the new York Academy of Sciences 679: 325-329, 1993

Neuropathologic effects of phenylmethylsulfonyl fluoride (PMSF)-induced promotion and protection in organophosphorus ester-induced delayed neuropathy (OPIDN) in hens. Neurotoxicology 20(5): 749-759, 1999

The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). Chemico-Biological Interactions 87(1-3): 383-393, 1993

The role of protein phosphorylation in organophosphorus compound induced delayed neurotoxicity opidn. Journal of Neurochemistry 52(Suppl.): S198, 1989

Studies on the molecular pathogenesis of organophosphorus compound-induced delayed neurotoxicity (OPIDN). Insecticide action: from molecule to organism edited by Toshio Narahashi and ice E Chambers: 216, 1989

The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN). Chemico-Biological Interactions 87(1-3): 395-406, 1993

Rodent susceptibility to organophosphate induced delayed neuropathy opidn. Abstracts of Papers American Chemical Society 199(1-2): AGRO 83, 1990

Biochemical evaluation of organophosphorus-ester induced delayed neurotoxicity (OPIDN): the role of 2',3'-cyclic nucleotide 3'-phosphohydrolase. Neurotoxicology 8(1): 211-222, 1987

Neuropathology of organophosphate-induced delayed neuropathy (OPIDN) in young chicks. Archives of Toxicology 68(5): 308-316, 1994

Potentiation of organophosphorus compound-induced delayed neurotoxicity (OPIDN) in the central and peripheral nervous system of the adult hen: distribution of axonal lesions. Journal of Toxicology and Environmental Health 51(6): 571-590, 1997

High-dose intravenous paraoxon exposure does not cause organophosphate-induced delayed neuropathy (OPIDN) in mini pigs. Journal of Applied Toxicology 21(4): 263-268, 2001